Table. 1.

Simple experimental grouping

Group Modeling drugs Treatments
Control 10% normal saline 1 μl 10% normal saline 30 days
Model 1–40 5 ug/ul 1 μl 10% normal saline 30 days
FN 1–40 5 ug/ul 1 μl FN 80 mg/kg 30 days

FN, fibrauretine; Aβ, amyloid β.

Korean J Physiol Pharmacol 2024;28:361-377 https://doi.org/10.4196/kjpp.2024.28.4.361
© Korean J Physiol Pharmacol